Synapse 3D With Intravascular Indocyanine Green

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Non-small Cell Lung CancerPrimary Neoplasm
Interventions
DEVICE

Synapse 3D Lung Modelling

The 3D virtual models provided by Synapse 3D will be made by experts in medical image analysis using the high-resolution CT scans. Patients will have 3D virtual reconstructions of their pulmonary anatomy with the target lesion created pre-operatively.

DRUG

IC-Green (ICG)

ICG will be prepared as a sterile solution (2.5 mg/10mL) for injection. After vascular ligation, a 6 to 8mL bolus of ICG solution will be injected into the peripheral vein catheter, followed by a 10mL saline solution bolus. The Firefly camera will then be used for the NIF imaging. It is expected that the entire lung, except the segment which was previously isolated from blood supply, will fluoresce within 30-40 seconds, exhibiting a green hue. The surgeon will perform the pulmonary resection and the resected 'dark' lung segment will be immediately evaluated by a pathologist, depending on the pathologist findings the operation may be concluded or the patient will receive a pulmonary lobectomy.

Trial Locations (1)

L8N 4A6

RECRUITING

St. Josephs Healthcare Hamilton, Hamilton

All Listed Sponsors
lead

St. Joseph's Healthcare Hamilton

OTHER